John Harold Leaman serves as Executive at IMPEL PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, John Harold Leaman has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved receiving (via award) 4,058 shares valued at $0.
John Harold Leaman currently holds 4,058 shares of IMPEL PHARMACEUTICALS INC (IMPL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Harold Leaman has been a net neutral trader of IMPL stock. They have purchased $0 and sold $0 worth of shares.
John Harold Leaman's most recent insider trade was on Dec 12, 2025, when they sold 4,058 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.75 |
| Discretionary |
| Dec 31, 2022 | IMPL | $0 | Option Exercise | 10,571 | $N/A | Discretionary |